Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / CDKN2C

CDKN2C

Basics

Aliases:
This biomarker is also known as:
  • CDKN6,
  • CDK6 inhibitor p18,
  • p18-INK4c,
  • cyclin-dependent kinase 6 inhibitor p18,
  • cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4),
  • INK4C,
  • p18-INK4C,
  • p18-INK6,
  • p18,
  • cyclin-dependent kinase 4 inhibitor C,
  • cyclin-dependent inhibitor,
  • Cyclin-dependent kinase 6 inhibitor,

Description…

cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)

Attributes

QA State: Under Review
Type: Gene
Short Name:
HGNC Name: CDKN2C

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Biomuta

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.